DC67515 · Updated 27 October 2026
CICL-207
Instructions for Use
Before use
Check the supplied lot number, batch COA, approved SDS, quantity and retest date. Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light.
For small quantities of viscous or oily lipid, volumetric transfer can reduce weighing losses. Confirm solvent compatibility and solubility before preparing a stock; calculated volumes do not establish solubility.
Stock-solution planning
Volume (mL) = mass (mg) × 1000 / [molecular weight × concentration (mM)].
| Mass | 10 mM | 20 mM |
|---|---|---|
| 10 mg | 0.9752 mL | 0.4876 mL |
| 25 mg | 2.4380 mL | 1.2190 mL |
| 50 mg | 4.8761 mL | 2.4380 mL |
| 100 mg | 9.7521 mL | 4.8761 mL |
Literature formulation reference
| Component | DC Chemicals product | Molecular weight | Molar ratio | Mass at 1 µmol total lipid (mg) |
|---|---|---|---|---|
| CICL-207 | DC67515 | 1025.416 | Not assigned | Not calculable from disclosed data |
| DSPC | DC57005 | 790.15 | Not assigned | Not calculable from disclosed data |
| Cholesterol | DCD-041 | 386.65 | Not assigned | Not calculable from disclosed data |
| DSG-PEG2000 | Not uniquely mapped | Not established | Not assigned | Not calculable from disclosed data |
| DSPE-PEG2000-maleimide | Not uniquely mapped | Not established | Not assigned | Not calculable from disclosed data |
The patent describes F50 as a five-lipid system with a targeting ligand in the immune-cell studies. DSG-PEG2000 is a distinct ingredient from DMG-PEG2000. Ingredient names are provided for source identification; antibody-bearing and undecorated particles must be distinguished when interpreting biological results.
Read the complete study conditions, biological results, tolerability and figures →